Skip to Main Content

Author Details

Almos Klekner
University of Debrecen
1997
79
27
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36892296[The effect of surgical psychoeducation on the outcome of spinal surgery].Ideggyogy Sz2023
36892296[The effect of surgical psychoeducation on the outcome of spinal surgery].Ideggyogy Sz2023
36765669MMP-9 as Prognostic Marker for Brain Tumours: A Comparative Study on Serum-Derived Small Extracellular Vesicles.Cancers (Basel)2023
37489544Astrocyte- and NMDA receptor-dependent slow inward currents differently contribute to synaptic plasticity in an age-dependent manner in mouse and human neocortex.Aging Cell2023
37489544Astrocyte- and NMDA receptor-dependent slow inward currents differently contribute to synaptic plasticity in an age-dependent manner in mouse and human neocortex.Aging Cell2023
36765669MMP-9 as Prognostic Marker for Brain Tumours: A Comparative Study on Serum-Derived Small Extracellular Vesicles.Cancers (Basel)2023
35013227Topographic mapping of the glioblastoma proteome reveals a triple-axis model of intra-tumoral heterogeneity.Nat Commun2022
36379303Mitochondrial DNA copy number changes, heteroplasmy, and mutations in plasma-derived exosomes and brain tissue of glioblastoma patients.Mol Cell Probes2022
36539587Mapping the functional expression of auxiliary subunits of K<sub>Ca</sub>1.1 in glioblastoma.Sci Rep2022
35013227Topographic mapping of the glioblastoma proteome reveals a triple-axis model of intra-tumoral heterogeneity.Nat Commun2022
36539587Mapping the functional expression of auxiliary subunits of K<sub>Ca</sub>1.1 in glioblastoma.Sci Rep2022
36379303Mitochondrial DNA copy number changes, heteroplasmy, and mutations in plasma-derived exosomes and brain tissue of glioblastoma patients.Mol Cell Probes2022
34064637Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients.Int J Mol Sci2021
33808766Raman Spectral Signatures of Serum-Derived Extracellular Vesicle-Enriched Isolates May Support the Diagnosis of CNS Tumors.Cancers (Basel)2021
34064637Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients.Int J Mol Sci2021
33741928The transcriptional landscape of Shh medulloblastoma.Nat Commun2021
33730118[The role of low grade glioma prognostic factors in therapeutic choices - summary of international literature and recommendations with conclusions].Magy Onkol2021
34576168Novel Concepts of Glioblastoma Therapy Concerning Its Heterogeneity.Int J Mol Sci2021
33741928The transcriptional landscape of Shh medulloblastoma.Nat Commun2021
33730118[The role of low grade glioma prognostic factors in therapeutic choices - summary of international literature and recommendations with conclusions].Magy Onkol2021
33808766Raman Spectral Signatures of Serum-Derived Extracellular Vesicle-Enriched Isolates May Support the Diagnosis of CNS Tumors.Cancers (Basel)2021
34576168Novel Concepts of Glioblastoma Therapy Concerning Its Heterogeneity.Int J Mol Sci2021
32132085Prognosis and Treatment Outcomes of Patients Undergoing Resection of Brain Metastases from Breast Cancer.Anticancer Res2020
32132085Prognosis and Treatment Outcomes of Patients Undergoing Resection of Brain Metastases from Breast Cancer.Anticancer Res2020
33259802Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.Cell2020
33035418[Prognostic significance of invasion in glioblastoma].Ideggyogy Sz2020
32731530Small Extracellular Vesicles Isolated from Serum May Serve as Signal-Enhancers for the Monitoring of CNS Tumors.Int J Mol Sci2020
33053907Novel Molecular Markers in Glioblastoma-Benefits of Liquid Biopsy.Int J Mol Sci2020
33053907Novel Molecular Markers in Glioblastoma-Benefits of Liquid Biopsy.Int J Mol Sci2020
33259802Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.Cell2020
33035418[Prognostic significance of invasion in glioblastoma].Ideggyogy Sz2020
32731530Small Extracellular Vesicles Isolated from Serum May Serve as Signal-Enhancers for the Monitoring of CNS Tumors.Int J Mol Sci2020
30655832Extracellular matrix differences in glioblastoma patients with different prognoses.Oncol Lett2019
31664194Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.Nature2019
30655832Extracellular matrix differences in glioblastoma patients with different prognoses.Oncol Lett2019
30986516Significance of liquid biopsy in glioblastoma - A review.J Biotechnol2019
31512637Influence of Oncotherapy and Clinical Parameters on Survival of Glioblastoma Patients: A Single Center Experience.Neurol India2019
31664194Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.Nature2019
31512637Influence of Oncotherapy and Clinical Parameters on Survival of Glioblastoma Patients: A Single Center Experience.Neurol India2019
30986516Significance of liquid biopsy in glioblastoma - A review.J Biotechnol2019
28161812Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.Pathol Oncol Res2018
30019219Heterogeneity within the PF-EPN-B ependymoma subgroup.Acta Neuropathol2018
30501525The Expressional Pattern of Invasion-Related Extracellular Matrix Molecules in CNS Tumors.Cancer Invest2018
28161812Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.Pathol Oncol Res2018
30019219Heterogeneity within the PF-EPN-B ependymoma subgroup.Acta Neuropathol2018
30501525The Expressional Pattern of Invasion-Related Extracellular Matrix Molecules in CNS Tumors.Cancer Invest2018
27529670Prognostic Role of the Expression of Invasion-Related Molecules in Glioblastoma.J Neurol Surg A Cent Eur Neurosurg2017
28654422PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.Oncotarget2017
28609654Intertumoral Heterogeneity within Medulloblastoma Subgroups.Cancer Cell2017
28739696Differences in Extracellular Matrix Composition and its Role in Invasion in Primary and Secondary Intracerebral Malignancies.Anticancer Res2017
  • 1 - 50 of 158

Recommended Authors

Felix Behling
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2015
Number of shared co-authors 4
Farshad Nassiri
Toronto Western Hospital, University Health Network, University of Toronto
Career Start Year 2010
Number of shared co-authors 13
Jenny Kan-Suen Pu
Queen Mary Hospital
Career Start Year 2009
Number of shared co-authors 4
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Matthias Preusser
Medical University of Vienna
Career Start Year 2003
Number of shared co-authors 39
Marco Skardelly
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2002
Number of shared co-authors 4
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Chul-Kee Park
College of Medicine, Seoul National University
Career Start Year 2000
Number of shared co-authors 10
Naoki Shinojima
Kumamoto University Hospital
Career Start Year 2000
Number of shared co-authors 6
Radim Jancalek
St. Anne University Hospital, Masaryk University
Career Start Year 1999
Number of shared co-authors 0
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 20
Jorge A Gutierrez
Case Western Reverse University School of Medicine
Career Start Year 1996
Number of shared co-authors 1
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 18
Ho-Shin Gwak
National Cancer Center
Career Start Year 1994
Number of shared co-authors 1
Ganesh Rao
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1994
Number of shared co-authors 21
Heon Yoo
Neuro-Oncology Clinic, National Cancer Center
Career Start Year 1993
Number of shared co-authors 1
Robert J Weil
Rhode Island Hospital
Career Start Year 1992
Number of shared co-authors 3
G??nther Stockhammer
Medical University of Innsbruck
Career Start Year 1990
Number of shared co-authors 2
Bob S Carter
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1990
Number of shared co-authors 3
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 6
Marica Eoli
Fondazione IRCCS Istituto Neurologico Carlo Besta
Career Start Year 1988
Number of shared co-authors 7
Motoo Nagane
Kyorin University Faculty of Medicine
Career Start Year 1988
Number of shared co-authors 5
Christine Marosi
Medical University of Vienna
Career Start Year 1987
Number of shared co-authors 3
Michael Weller
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 54
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 21
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 8
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Career Start Year 1979
Number of shared co-authors 5
Gregory N Fuller
MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 29
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Career Start Year 1974
Number of shared co-authors 24

Collaborators

L??szl?? Bogn??r
BRC-Biological Research Centre
Co-authored papers 45
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 22
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 16
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 16
Uri Tabori
Co-authored papers 15
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 14
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 14
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers 12
Jennifer A Chan
Dana-Farber Cancer Institute
Co-authored papers 12
Eric Bouffet
The Hospital for Sick Children
Co-authored papers 12
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers 12
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 12
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 11
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 11
Seung-Ki Kim
Seoul National University Children's Hospital
Co-authored papers 11
Peter B Dirks
The Hospital for Sick Children, University of Toronto
Co-authored papers 10
Ian F Pollack
University of Pittsburgh School of Medicine
Co-authored papers 10
Joshua B Rubin
Washington University in St. Louis
Co-authored papers 10
Wies??awa Grajkowska
Children's Memorial Health Institute
Co-authored papers 10
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 10
Pim J French
Erasmus MC Cancer Institute
Co-authored papers 10
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 10
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Co-authored papers 9
David Malkin
Hospital for Sick Children
Co-authored papers 9
Maryam Fouladi
Co-authored papers 9
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 9
Florence M G Cavalli
Institut Curie, PSL Research University
Co-authored papers 9
William A Weiss
University of California san francisco
Co-authored papers 9
Betty Luu
University of Wollongong
Co-authored papers 9
Toshihiro Kumabe
Kitasato University School of Medicine
Co-authored papers 9
Release 1.2